Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil as Adjunct to Fluoxetine in Major Depressive Disorder
NCT05030623Phase 2Withdrawn
- Sponsor
- Sadat City University
- Start
- Aug 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in major depressive disorder (MDD), sponsored by Sadat City University. Planned start Aug 2021; status: withdrawn.
02
Drugs
tadalafil
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05030623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05030623.